![Ellen Rose](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ellen Rose
Investor Relations Kontakt bei
LB PHARMACEUTICALS INC
Profil
Ellen Rose is Senior Vice President-Corporate Affairs at LB Pharmaceuticals, Inc. since 2026.
Former roles include Director-Communications at ALZA Corp., Head-Communications & Media Relations at Prothena Corp.
Plc, and Senior VP-Communications & Investor Relations at Lyell Immunopharma, Inc. Education includes undergraduate studies at Stanford University.
Aktive Positionen von Ellen Rose
| Unternehmen | Position | Beginn |
|---|---|---|
| LB PHARMACEUTICALS INC | Investor Relations Kontakt | 06.01.2026 |
Ehemalige bekannte Positionen von Ellen Rose
| Unternehmen | Position | Ende |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Investor Relations Kontakt | - |
| ALZA CORPORATION | Public Communications Contact | - |
| PROTHENA CORPORATION PLC | Public Communications Contact | - |
Ausbildung von Ellen Rose
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
